Tech Company Financing Transactions
CAMP4 Therapeutics Funding Round
On 6/1/2018, CAMP4 Therapeutics raised $30 million in Series A funding from Andreessen Horowitz, Polaris Partners and The Kraft Group.
Transaction Overview
Company Name
Announced On
6/1/2018
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Series A
Investors
Andreessen Horowitz (Lead Investor) (Jorge Conde)
Polaris Partners (Lead Investor) (Amir Nashat)
Proceeds Purpose
Proceeds from the financing will be used to expand the use of its Platform to other human cell types and accelerate collaborations with partners toward novel target discoveries and new applications for existing chemistries, extending their life cycle and value into areas previously not considered.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1 Kendall Sq. Bldg 1400 West 3rd Floor
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Undisclosed
Website
Email Address
Overview
CAMP4 is focused on addressing the fundamental cause of disease by controlling the output of genes central to disease. By taking advantage of the gene circuitry code, CAMP4 is able to control gene production through signaling pathways the cell is already utilizing to regulate gene expression.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Josh Mandel-Brehm
Chief Scientific Officer
David Bumcrot
Vice President
Alfica Sehgal
VP - Bus. Development
Kelly Gold
VP - Human Resources
Michelle Gates
VP - Operations
Caleb Moore
Browse more venture capital transactions:
Prev: 6/1/2018: Ocrolus venture capital transaction
Next: 6/1/2018: Emagispace venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs